Periodic Reporting for period 3 - TUDCA-ALS (Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS))

Amyotrophic lateral sclerosis (ALS) is a chronic non-communicable neurodegenerative rare disease that affects motor neurons in the brain, brainstem and spinal cord, resulting in progressive weakness and atrophy of voluntary skeletal muscles. ALS has an estimated prevalence of...